Dose response of icenticaftor in patients with COPD and chronic bronchitis on triple inhaled therapy
F. Franssen (Maastricht, Netherlands), F. Martinez (New York, United States), J. Wedzicha (London, United Kingdom), J. Eckert (Basel, Switzerland), B. Knorr (New Jersey, United States), R. Parlikar (Hyderabad, India), A. Tanase (Basel, Switzerland), C. Gessner (Leipzig, Germany)
Source: International Congress 2022 – ALERT 1: COPD and hospital management
Session: ALERT 1: COPD and hospital management
Session type: Clinical trials session
Number: 710
  
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Franssen (Maastricht, Netherlands), F. Martinez (New York, United States), J. Wedzicha (London, United Kingdom), J. Eckert (Basel, Switzerland), B. Knorr (New Jersey, United States), R. Parlikar (Hyderabad, India), A. Tanase (Basel, Switzerland), C. Gessner (Leipzig, Germany). Dose response of icenticaftor in patients with COPD and chronic bronchitis on triple inhaled therapy. 710
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|